Navigation Links
ASU, Phoenix Children's Hospital expand biomedical research partnership
Date:2/4/2013

TEMPE, Ariz. -- Research to seek a cure for malignant brain tumors and more precise diagnoses of acute brain injuries will be the focus of collaborations between Arizona State University biomedical engineers and clinician-scientists at the Barrow Neurological Institute at Phoenix Children's Hospital.

The projects are being funded by two $30,000 awards from a seed grant program recently established by Barrow at Phoenix Children's Hospital and the School of Biological and Health Systems Engineering, one of ASU's Ira A. Fulton Schools of Engineering.

The program's goal is to promote interdisciplinary collaborations between ASU biomedical engineers and clinical faculty at Phoenix Children's Hospital that will target high-priority medical challenges, including but not limited to biomarker discovery and validation for nervous system disorders, development of medical devices and the comparative effectiveness of treatments for neurological and musculoskeletal disorders.

One of the projects will team ASU assistant biomedical engineering professor Sarah Stabenfeldt with Jonathan Lifshitz, director of the Barrow at Phoenix Children's Hospital Translational Neurotrauma Research Program.

The other project will be led by ASU assistant biomedical engineering professor Vikram Kodibagkar and Ratan Bhardwaj, pediatric neurosurgeon at Barrow at Phoenix Children's Hospital.

Stabenfeldt and Lifshitz will explore the complex network of biomolecules called the extracellular matrix that support the structure of the nervous system and its integration with the body's vascular system.

In cases of injury such as traumatic brain injury, the extracurricular matrix could be disturbed and impair neurological function. Their project will uncover the extent of changes the extracellular matrix undergoes after acute brain injury.

They will then correlate the molecular changes with neurological functions, with the intent for changes in the extracurricular matrix to serve as indicators (or "biomarkers") of severe brain injuries.

Kodibagkar and Bhardwaj will explore a possible cure for malignant brain tumors based on fundamental processes involved in the body's own immune system.

They plan to develop a personalized vaccine capable of finding and killing malignant cells while leaving normal brain cells unharmed.

They are proposing experiments to test the strategy, which involves monitoring tumor growth and the response to the immunotherapy method using Magnetic Resonance Imaging (MRI).

Kodibagkar and Bhardwaj will also employ a highly specialized MRI technique, Diffusion Tensor Tractography, to visualize changes in white-matter tracts in the vicinity of tumors as this therapy method is employed.

They will aim to translate the pre-clinical results into a safe and efficient path for clinical studies, with the hope of harnessing the regenerative capabilities of body's immune system to safely and effectively kill brain tumor cells.

In early 2014 the two research teams are to present results of their pilot projects to officials of Barrow at Phoenix Children's Hospital and the School of Biological and Health Systems Engineering. The reports are to include additional research goals for proposals to seek funding from federal agencies, including the National Institutes of Health and the Department of Defense.

"We already have successful connections with Phoenix Children's Hospital. But with the level of expertise of our biomedical engineering faculty at ASU and the hospital's clinicians, we thought we had the potential to accomplish more," says Marco Santello, director of the School of Biological and Health Systems Engineering.

Santello says he and Barrow at Phoenix Children's Hospital director P. David Adelson, M.D., proposed the seed grant program "as a way to be proactive about expanding these collaborations."


'/>"/>

Contact: Joe Kullman
joe.kullman@asu.edu
480-965-8122
Arizona State University
Source:Eurekalert

Related medicine news :

1. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
2. 4,000 analytics experts come to Phoenix for INFORMS Annual Meeting
3. The Goodie Boxes - Providing Affordable Meals for Families begins Operations in the Phoenix, Scottsdale, Arizona Area
4. Phoenix Synergy Discusses securing computer networks at the AZPMA conference in Las Vegas
5. Higher-spending hospitals have fewer deaths for emergency patients
6. Predictors identified for rehospitalization among post-acute stroke patients
7. More Smog Might Mean More Hospitalizations
8. After Hospitalization, Men More Likely to Show Up in ER
9. Choosing the right hospital may save your babys life
10. Heart Attack Survival Varies Widely Among Hospitals, Study Finds
11. In Some Brain Bleeds, Patients Do Better at High-Volume Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , ... January 24, 2017 , ... i2i Population Health, ... chief financial officer. , “Cary’s broad financial background is an excellent ... the strategic planning and day-to-day financial operations skills we need to take the company ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve ... round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder ... 2017. The entrepreneurs will showcase their businesses on February 6, 2017, at Under ...
(Date:1/24/2017)... ... , ... His message has been heard by more than 100,000 students and ... , Joel Feldman, has reached his biggest national audience yet: the three million daily ... newspapers in circulation in the country, and he hopes it will help spread his ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical economic ... the Frank Hawkins Kenan Institute of Private Enterprise at the University ... makers identified concrete solutions at the “What’s Next, America?” conference at the Kenan ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a ... (NMIs) and co-funded by the European Union (EU), was completed in May 2015. The ... instead being maintained and used in air, which presents some challenges to establishing traceability ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... SAN FRANCISCO , Jan. 24, 2017 /PRNewswire/ ... formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of ... In-Fusion® Cloning Primer Design Tool, powered by TeselaGen Biotechnology, ... is a unique method that seamlessly joins together linear ... free, online primer design tool facilitates easy design and ...
(Date:1/24/2017)... 2017 Sherpa Clinical Packaging ( www.sherpaclinical.com ... is pleased to announce the appointment of Kevin Rosenthal as ... Sherpa team to lead Sherpa,s Operations group and ... excellence. Kevin is not new to ... He has extensive experience working for leading pharma ...
(Date:1/24/2017)... Pa. , Jan. 24, 2017   ... 2 biopharmaceutical company developing novel therapies for the ... today announced the appointment of four world-class key ... These new appointments join QR Pharma,s previous roster ... leadership and direction to support the development of ...
Breaking Medicine Technology: